1. Home
  2. AMZE vs NEUP Comparison

AMZE vs NEUP Comparison

Compare AMZE & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMZE
  • NEUP
  • Stock Information
  • Founded
  • AMZE 2019
  • NEUP 1996
  • Country
  • AMZE United States
  • NEUP United States
  • Employees
  • AMZE N/A
  • NEUP N/A
  • Industry
  • AMZE Beverages (Production/Distribution)
  • NEUP
  • Sector
  • AMZE Consumer Staples
  • NEUP
  • Exchange
  • AMZE Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • AMZE 12.3M
  • NEUP 10.3M
  • IPO Year
  • AMZE 2021
  • NEUP N/A
  • Fundamental
  • Price
  • AMZE $0.50
  • NEUP $4.10
  • Analyst Decision
  • AMZE
  • NEUP Strong Buy
  • Analyst Count
  • AMZE 0
  • NEUP 2
  • Target Price
  • AMZE N/A
  • NEUP $28.00
  • AVG Volume (30 Days)
  • AMZE 216.7K
  • NEUP 4.7M
  • Earning Date
  • AMZE 11-14-2025
  • NEUP 11-21-2025
  • Dividend Yield
  • AMZE N/A
  • NEUP N/A
  • EPS Growth
  • AMZE N/A
  • NEUP N/A
  • EPS
  • AMZE N/A
  • NEUP N/A
  • Revenue
  • AMZE $1,054,111.00
  • NEUP $15,649,448.00
  • Revenue This Year
  • AMZE $6,741.66
  • NEUP N/A
  • Revenue Next Year
  • AMZE $100.61
  • NEUP N/A
  • P/E Ratio
  • AMZE N/A
  • NEUP N/A
  • Revenue Growth
  • AMZE N/A
  • NEUP N/A
  • 52 Week Low
  • AMZE $0.48
  • NEUP $2.90
  • 52 Week High
  • AMZE $22.54
  • NEUP $126.00
  • Technical
  • Relative Strength Index (RSI)
  • AMZE 23.16
  • NEUP 32.80
  • Support Level
  • AMZE $1.00
  • NEUP $3.93
  • Resistance Level
  • AMZE $0.95
  • NEUP $4.50
  • Average True Range (ATR)
  • AMZE 0.15
  • NEUP 0.65
  • MACD
  • AMZE -0.03
  • NEUP -0.28
  • Stochastic Oscillator
  • AMZE 1.67
  • NEUP 7.46

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: